Louis Gidel, M.D. State of the Science Critical Care Best Practices Symposium, 10th Annual Evaluation

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree

	5	4	3	2	1
The information and/or skills learned will enhance my professional competence or ability.	The information and/or skills learned will enhance my professional competence or ability. - 5	The information and/or skills learned will enhance my professional competence or ability. - 4	The information and/or skills learned will enhance my professional competence or ability. - 3	The information and/or skills learned will enhance my professional competence or ability. - 2	The information and/or skills learned will enhance my professional competence or ability. - 1
This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients.	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 5	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 4	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 3	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 2	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 1

How confident are you in your ability to: *

5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence Not applicable|Not applicable

	5	4	3	2	1	Not applicable
Properly use advanced pharmacotherapy in critical care medicine.	Properly use advanced pharmacotherapy in critical care medicine. - 5	Properly use advanced pharmacotherapy in critical care medicine. - 4	Properly use advanced pharmacotherapy in critical care medicine. - 3	Properly use advanced pharmacotherapy in critical care medicine. - 2	Properly use advanced pharmacotherapy in critical care medicine. - 1	Properly use advanced pharmacotherapy in critical care medicine. - Not applicable
Implement new FDA approved therapies for cardiogenic shock.	Implement new FDA approved therapies for cardiogenic shock. - 5	Implement new FDA approved therapies for cardiogenic shock. - 4	Implement new FDA approved therapies for cardiogenic shock. - 3	Implement new FDA approved therapies for cardiogenic shock. - 2	Implement new FDA approved therapies for cardiogenic shock. - 1	Implement new FDA approved therapies for cardiogenic shock. - Not applicable
Apply the ROX index to the use of high flow therapy in critically ill patients.	Apply the ROX index to the use of high flow therapy in critically ill patients. - 5	Apply the ROX index to the use of high flow therapy in critically ill patients. - 4	Apply the ROX index to the use of high flow therapy in critically ill patients. - 3	Apply the ROX index to the use of high flow therapy in critically ill patients. - 2	Apply the ROX index to the use of high flow therapy in critically ill patients. - 1	Apply the ROX index to the use of high flow therapy in critically ill patients. - Not applicable
Implement evidence-based guidelines for remote ventilator management.	Implement evidence-based guidelines for remote ventilator management. - 5	Implement evidence-based guidelines for remote ventilator management. - 4	Implement evidence-based guidelines for remote ventilator management. - 3	Implement evidence-based guidelines for remote ventilator management. - 2	Implement evidence-based guidelines for remote ventilator management. - 1	Implement evidence-based guidelines for remote ventilator management. - Not applicable

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied NA= Not Applicable

	5	4	3	2	1	NA
Understanding Hemodynamic Principles of Cardiogenic Shock using Pressure Volume Loops - Arvind Bhimaraj, M.D., MPH, FACC, FHFSA	Understanding Hemodynamic Principles of Cardiogenic Shock using Pressure Volume Loops - Arvind Bhimaraj, M.D., MPH, FACC, FHFSA - 5	Understanding Hemodynamic Principles of Cardiogenic Shock using Pressure Volume Loops - Arvind Bhimaraj, M.D., MPH, FACC, FHFSA - 4	Understanding Hemodynamic Principles of Cardiogenic Shock using Pressure Volume Loops - Arvind Bhimaraj, M.D., MPH, FACC, FHFSA - 3	Understanding Hemodynamic Principles of Cardiogenic Shock using Pressure Volume Loops - Arvind Bhimaraj, M.D., MPH, FACC, FHFSA - 2	Understanding Hemodynamic Principles of Cardiogenic Shock using Pressure Volume Loops - Arvind Bhimaraj, M.D., MPH, FACC, FHFSA - 1	Understanding Hemodynamic Principles of Cardiogenic Shock using Pressure Volume Loops - Arvind Bhimaraj, M.D., MPH, FACC, FHFSA - NA
SUP in 2023: An Update on Stress Ulcer Prophylaxis - Jeffrey Barletta, Pharm.D.	SUP in 2023: An Update on Stress Ulcer Prophylaxis - Jeffrey Barletta, Pharm.D. - 5	SUP in 2023: An Update on Stress Ulcer Prophylaxis - Jeffrey Barletta, Pharm.D. - 4	SUP in 2023: An Update on Stress Ulcer Prophylaxis - Jeffrey Barletta, Pharm.D. - 3	SUP in 2023: An Update on Stress Ulcer Prophylaxis - Jeffrey Barletta, Pharm.D. - 2	SUP in 2023: An Update on Stress Ulcer Prophylaxis - Jeffrey Barletta, Pharm.D. - 1	SUP in 2023: An Update on Stress Ulcer Prophylaxis - Jeffrey Barletta, Pharm.D. - NA
The Latest in Cardiogenic Shock 2023 - Sandra Viviana Chaparro, M.D.	The Latest in Cardiogenic Shock 2023 - Sandra Viviana Chaparro, M.D. - 5	The Latest in Cardiogenic Shock 2023 - Sandra Viviana Chaparro, M.D. - 4	The Latest in Cardiogenic Shock 2023 - Sandra Viviana Chaparro, M.D. - 3	The Latest in Cardiogenic Shock 2023 - Sandra Viviana Chaparro, M.D. - 2	The Latest in Cardiogenic Shock 2023 - Sandra Viviana Chaparro, M.D. - 1	The Latest in Cardiogenic Shock 2023 - Sandra Viviana Chaparro, M.D. - NA
Sepsis: Where Are We Now? - Kathleen M. Vollman MSN, R.N.	Sepsis: Where Are We Now? - Kathleen M. Vollman MSN, R.N. - 5	Sepsis: Where Are We Now? - Kathleen M. Vollman MSN, R.N. - 4	Sepsis: Where Are We Now? - Kathleen M. Vollman MSN, R.N. - 3	Sepsis: Where Are We Now? - Kathleen M. Vollman MSN, R.N. - 2	Sepsis: Where Are We Now? - Kathleen M. Vollman MSN, R.N. - 1	Sepsis: Where Are We Now? - Kathleen M. Vollman MSN, R.N. - NA
Achieving Gender Equity in Critical Care - Gloria M. Rodríguez-Vega, M.D., FACP, FCCP, FNCS, MCCM	Achieving Gender Equity in Critical Care - Gloria M. Rodríguez-Vega, M.D., FACP, FCCP, FNCS, MCCM - 5	Achieving Gender Equity in Critical Care - Gloria M. Rodríguez-Vega, M.D., FACP, FCCP, FNCS, MCCM - 4	Achieving Gender Equity in Critical Care - Gloria M. Rodríguez-Vega, M.D., FACP, FCCP, FNCS, MCCM - 3	Achieving Gender Equity in Critical Care - Gloria M. Rodríguez-Vega, M.D., FACP, FCCP, FNCS, MCCM - 2	Achieving Gender Equity in Critical Care - Gloria M. Rodríguez-Vega, M.D., FACP, FCCP, FNCS, MCCM - 1	Achieving Gender Equity in Critical Care - Gloria M. Rodríguez-Vega, M.D., FACP, FCCP, FNCS, MCCM - NA
Saving the Heart, A Team Effort - Sandra Viviana Chaparro, M.D.	Saving the Heart, A Team Effort - Sandra Viviana Chaparro, M.D. - 5	Saving the Heart, A Team Effort - Sandra Viviana Chaparro, M.D. - 4	Saving the Heart, A Team Effort - Sandra Viviana Chaparro, M.D. - 3	Saving the Heart, A Team Effort - Sandra Viviana Chaparro, M.D. - 2	Saving the Heart, A Team Effort - Sandra Viviana Chaparro, M.D. - 1	Saving the Heart, A Team Effort - Sandra Viviana Chaparro, M.D. - NA
Mechanical Circulatory Support for the Management of Cardiogenic Shock - Hany Samir, M.D., FCCP, M.B., BCh	Mechanical Circulatory Support for the Management of Cardiogenic Shock - Hany Samir, M.D., FCCP, M.B., BCh - 5	Mechanical Circulatory Support for the Management of Cardiogenic Shock - Hany Samir, M.D., FCCP, M.B., BCh - 4	Mechanical Circulatory Support for the Management of Cardiogenic Shock - Hany Samir, M.D., FCCP, M.B., BCh - 3	Mechanical Circulatory Support for the Management of Cardiogenic Shock - Hany Samir, M.D., FCCP, M.B., BCh - 2	Mechanical Circulatory Support for the Management of Cardiogenic Shock - Hany Samir, M.D., FCCP, M.B., BCh - 1	Mechanical Circulatory Support for the Management of Cardiogenic Shock - Hany Samir, M.D., FCCP, M.B., BCh - NA
Categorizing Cardiogenic Shock: Contemporary Perspectives of Etiology and Phenotypes - Arvind Bhimaraj, M.D., MPH, FACC, FHFSA	Categorizing Cardiogenic Shock: Contemporary Perspectives of Etiology and Phenotypes - Arvind Bhimaraj, M.D., MPH, FACC, FHFSA - 5	Categorizing Cardiogenic Shock: Contemporary Perspectives of Etiology and Phenotypes - Arvind Bhimaraj, M.D., MPH, FACC, FHFSA - 4	Categorizing Cardiogenic Shock: Contemporary Perspectives of Etiology and Phenotypes - Arvind Bhimaraj, M.D., MPH, FACC, FHFSA - 3	Categorizing Cardiogenic Shock: Contemporary Perspectives of Etiology and Phenotypes - Arvind Bhimaraj, M.D., MPH, FACC, FHFSA - 2	Categorizing Cardiogenic Shock: Contemporary Perspectives of Etiology and Phenotypes - Arvind Bhimaraj, M.D., MPH, FACC, FHFSA - 1	Categorizing Cardiogenic Shock: Contemporary Perspectives of Etiology and Phenotypes - Arvind Bhimaraj, M.D., MPH, FACC, FHFSA - NA
Fluid and Vasopressor Therapy in Shock: A Pharmacist’s Perspective - Jeffrey Barletta, Pharm.D.	Fluid and Vasopressor Therapy in Shock: A Pharmacist’s Perspective - Jeffrey Barletta, Pharm.D. - 5	Fluid and Vasopressor Therapy in Shock: A Pharmacist’s Perspective - Jeffrey Barletta, Pharm.D. - 4	Fluid and Vasopressor Therapy in Shock: A Pharmacist’s Perspective - Jeffrey Barletta, Pharm.D. - 3	Fluid and Vasopressor Therapy in Shock: A Pharmacist’s Perspective - Jeffrey Barletta, Pharm.D. - 2	Fluid and Vasopressor Therapy in Shock: A Pharmacist’s Perspective - Jeffrey Barletta, Pharm.D. - 1	Fluid and Vasopressor Therapy in Shock: A Pharmacist’s Perspective - Jeffrey Barletta, Pharm.D. - NA
Current Strategies for Remote Ventilator Management for the Critically Ill - Michelle S. Rausen, M.S., RRT, RRT-NPS	Current Strategies for Remote Ventilator Management for the Critically Ill - Michelle S. Rausen, M.S., RRT, RRT-NPS - 5	Current Strategies for Remote Ventilator Management for the Critically Ill - Michelle S. Rausen, M.S., RRT, RRT-NPS - 4	Current Strategies for Remote Ventilator Management for the Critically Ill - Michelle S. Rausen, M.S., RRT, RRT-NPS - 3	Current Strategies for Remote Ventilator Management for the Critically Ill - Michelle S. Rausen, M.S., RRT, RRT-NPS - 2	Current Strategies for Remote Ventilator Management for the Critically Ill - Michelle S. Rausen, M.S., RRT, RRT-NPS - 1	Current Strategies for Remote Ventilator Management for the Critically Ill - Michelle S. Rausen, M.S., RRT, RRT-NPS - NA
Humanizing the Intensive Care Unit - Gloria M. Rodríguez-Vega, M.D.	Humanizing the Intensive Care Unit - Gloria M. Rodríguez-Vega, M.D. - 5	Humanizing the Intensive Care Unit - Gloria M. Rodríguez-Vega, M.D. - 4	Humanizing the Intensive Care Unit - Gloria M. Rodríguez-Vega, M.D. - 3	Humanizing the Intensive Care Unit - Gloria M. Rodríguez-Vega, M.D. - 2	Humanizing the Intensive Care Unit - Gloria M. Rodríguez-Vega, M.D. - 1	Humanizing the Intensive Care Unit - Gloria M. Rodríguez-Vega, M.D. - NA
High-Flow Oxygen Therapy: Current Applications - Michelle S. Rausen, M.S., RRT, RRT-NPS	High-Flow Oxygen Therapy: Current Applications - Michelle S. Rausen, M.S., RRT, RRT-NPS - 5	High-Flow Oxygen Therapy: Current Applications - Michelle S. Rausen, M.S., RRT, RRT-NPS - 4	High-Flow Oxygen Therapy: Current Applications - Michelle S. Rausen, M.S., RRT, RRT-NPS - 3	High-Flow Oxygen Therapy: Current Applications - Michelle S. Rausen, M.S., RRT, RRT-NPS - 2	High-Flow Oxygen Therapy: Current Applications - Michelle S. Rausen, M.S., RRT, RRT-NPS - 1	High-Flow Oxygen Therapy: Current Applications - Michelle S. Rausen, M.S., RRT, RRT-NPS - NA
Do Bundles Improve Outcomes? - Kathleen M. Vollman, MSN, R.N.	Do Bundles Improve Outcomes? - Kathleen M. Vollman, MSN, R.N. - 5	Do Bundles Improve Outcomes? - Kathleen M. Vollman, MSN, R.N. - 4	Do Bundles Improve Outcomes? - Kathleen M. Vollman, MSN, R.N. - 3	Do Bundles Improve Outcomes? - Kathleen M. Vollman, MSN, R.N. - 2	Do Bundles Improve Outcomes? - Kathleen M. Vollman, MSN, R.N. - 1	Do Bundles Improve Outcomes? - Kathleen M. Vollman, MSN, R.N. - NA
Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Hany Samir, M.D., FCCP, M.B., BCh	Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Hany Samir, M.D., FCCP, M.B., BCh - 5	Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Hany Samir, M.D., FCCP, M.B., BCh - 4	Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Hany Samir, M.D., FCCP, M.B., BCh - 3	Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Hany Samir, M.D., FCCP, M.B., BCh - 2	Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Hany Samir, M.D., FCCP, M.B., BCh - 1	Extracorporeal Cardiopulmonary Resuscitation (ECPR) - Hany Samir, M.D., FCCP, M.B., BCh - NA

Was this course fair, balanced and without commercial bias? *

Yes

If you checked "No,” please explain why: *

As a result of my participation in this Symposium, I commit to make the following changes to my clinical practice: *

I will take into consideration the effect of proton pump inhibitors with histamine-2-receptor antagonists on clinically important bleedings and on adverse events.

I will apply new cardiogenic shock guidelines when treating patients in the ICU.

I have implemented new FDA approved therapies for cardiogenic shock

I will apply the ROX index to the use of high flow therapy in critically ill patients

I will implement evidence-based guidelines for remote ventilator management

Not applicable to my practice.

I do not agree with the recommendations presented.

I am retired.

What, if any, new skills/strategies will you apply in your clinical practice? *

What are the potential barriers or obstacles that might prevent you from implementing new strategies you learned at this activity? *

Comments

Name

Attestation *

Choose 1 option

I attest that I have participated in this live symposium in its entirety.

I attest that I have participated in _____ hours of instruction (max 6.5) during this live symposium.

hours attestation *

Hours attended

Leave this field blank

You are here

Louis Gidel, M.D. State of the Science Critical Care Best Practices Symposium, 10th Annual Evaluation